Oncotelic Therapeutics, Inc. Stock Issued During Period, Value, Other
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- Oncotelic Therapeutics, Inc. stock issued during period, value, other for the quarter ending 2026-06-30 was $32.73K.
- Oncotelic Therapeutics, Inc. stock issued during period, value, other for the quarter ending 2026-03-31 was $130.77K.
- Oncotelic Therapeutics, Inc. stock issued during period, value, other for fiscal 2019 was $238.09K, a 86.54% decline from fiscal 2018.
- Oncotelic Therapeutics, Inc. stock issued during period, value, other for fiscal 2018 was $1.77M.
| Period end | Stock Issued During Period, Value, Other 3 month | Stock Issued During Period, Value, Other 12 month |
|---|---|---|
| 2026-06-30 | $32.73K 10-Q · filed 2026-08-13 | |
| 2026-03-31 | $130.77K 10-Q · filed 2026-08-13 | |
| 2019-12-31 | $238.09K 10-K · filed 2021-04-15 | |
| 2018-12-31 | $1.77M 10-K · filed 2020-05-14 |